CHRS 营业利润历史(2016–2025)
Coherus Oncology, Inc. (CHRS) 年度营业利润历史(来自 SEC 财报)—— 每个财年的申报值。
-$181.1MFY2025 · FY2016 以来:-$115.9M → -$181.1M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | -$181.1M | +9.3% |
| FY2024 | -$199.7M | +1.7% |
| FY2023 | -$203.2M | +20.9% |
| FY2022 | -$256.9M | +2.6% |
| FY2021 | -$263.9M | -268.8% |
| FY2020 | $156.3M | +45.1% |
| FY2019 | $107.8M | +152.7% |
| FY2018 | -$204.4M | +11.9% |
| FY2017 | -$232.1M | -100.2% |
| FY2016 | -$115.9M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议